Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changsu Han

Showing results (131-140 of 276) with videos related to

Pageof 28
Sort By:
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 26, 2026
Brexpiprazole for the Treatment of Agitation Associated with Dementia due to Alzheimer's Disease: Clinical PerspectivesHayeon Kim, Kyung Ho Lee, Changsu Han, et al.
Journal of Psychiatric Research|April 9, 2015
Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysisChi-Un Pae, Sheng-Min Wang, Changsu Han, et al.
Psychiatry Research|March 15, 2011
Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophreniaAlessandro Serretti, Alberto Chiesa, Stefano Porcelli, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 25, 2021
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of SchizophreniaJung-Jin Kim, Chi-Un Pae, Changsu Han, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|November 2, 2019
The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective StudyChangsu Han, Sheng-Min Wang, Won-Myong Bahk, et al.
Neuropsychiatric Disease and Treatment|December 10, 2020
Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across AsiaGang Wang, Changsu Han, Chia-Yih Liu, et al.
Expert Review of Neurotherapeutics|October 9, 2012
Can botulinum toxin improve mood in depressed patients?Changsu Han, Geun-Young Park, Sheng-Min Wang, et al.
Expert Review of Clinical Pharmacology|September 13, 2017
Efficacy of antidepressants: bias in randomized clinical trials and related issuesSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
BMC Psychiatry|April 20, 2016
Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathwayEnrico Cocchi, Chiara Fabbri, Changsu Han, et al.
Journal of Molecular Neuroscience : MN|December 21, 2017
Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their RoleStefano Porcelli, Soo-Jung Lee, Changsu Han, et al.
Pageof 28

Showing results (131-140 of 276) with videos related to

Sort By:
Pageof 28
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 26, 2026
Brexpiprazole for the Treatment of Agitation Associated with Dementia due to Alzheimer's Disease: Clinical PerspectivesHayeon Kim, Kyung Ho Lee, Changsu Han, et al.
Journal of Psychiatric Research|April 9, 2015
Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysisChi-Un Pae, Sheng-Min Wang, Changsu Han, et al.
Psychiatry Research|March 15, 2011
Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophreniaAlessandro Serretti, Alberto Chiesa, Stefano Porcelli, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 25, 2021
Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of SchizophreniaJung-Jin Kim, Chi-Un Pae, Changsu Han, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|November 2, 2019
The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective StudyChangsu Han, Sheng-Min Wang, Won-Myong Bahk, et al.
Neuropsychiatric Disease and Treatment|December 10, 2020
Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across AsiaGang Wang, Changsu Han, Chia-Yih Liu, et al.
Expert Review of Neurotherapeutics|October 9, 2012
Can botulinum toxin improve mood in depressed patients?Changsu Han, Geun-Young Park, Sheng-Min Wang, et al.
Expert Review of Clinical Pharmacology|September 13, 2017
Efficacy of antidepressants: bias in randomized clinical trials and related issuesSheng-Min Wang, Changsu Han, Soo-Jung Lee, et al.
BMC Psychiatry|April 20, 2016
Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathwayEnrico Cocchi, Chiara Fabbri, Changsu Han, et al.
Journal of Molecular Neuroscience : MN|December 21, 2017
Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their RoleStefano Porcelli, Soo-Jung Lee, Changsu Han, et al.
Pageof 28